Skip to content
Biodatica
Start free

Investigator

Andrew E. Levin

KEPHERA DIAGNOSTICS, LLC · funded by NHLBI, NIAID

Companies
3

Resolved onto their grants.

Grants
7

Federal awards on file.

Non-dilutive funding
$4.9M

Summed across those awards.

First award
Aug 7, 2018

Latest Sep 15, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Peptide-based ELISA for laboratory diagnosis of sarcoidosis

    $978k

    Sep 15, 2025NHLBIKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11185844 (opens the source filing in a new tab)

  2. R44

    Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients

    $124k

    May 1, 2025NIAIDKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11382998 (opens the source filing in a new tab)

  3. R43

    Diagnostic assay for congenital Chagas disease

    $303k

    May 1, 2024NIAIDKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11080292 (opens the source filing in a new tab)

  4. R44

    Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients

    $876k

    Jan 10, 2020NIAIDKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11067754 (opens the source filing in a new tab)

  5. R44

    Biomarker-Based Test of Cure for Chagas Disease

    $906k

    Jul 16, 2019NIAIDKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11145824 (opens the source filing in a new tab)

  6. R44

    Hybrid ELISA: Simple and specific one-tier assay for Lyme disease

    $715k

    Mar 6, 2019NIAIDKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11158727 (opens the source filing in a new tab)

  7. R44

    Point-of-care diagnostic test for T. cruzi (Chagas) infection

    $1.0M

    Aug 7, 2018NIAIDKEPHERA DIAGNOSTICS, LLCNIH RePORTER · 11061837 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources